Clinical Trials on Lung, Hyperlucent in China

Total 5030 results

Peking University Third Hospital

Completed

Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions：A Preliminary Lung Centered Study

Carcinoma of the Lungs

China
Peking University First Hospital
Peking University Cancer Hospital & Institute

Terminated

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Carcinoma, Non-Small-Cell Lung | Surgery | Dexamethasone | Long-term Effects Secondary to Cancer Therapy in Adults | Flubiprofen Axetil

China
Peking University First Hospital

Completed

Prophylactic Penehyclidine Hydrochloride Inhalation and 3-year Outcome After Surgery

Postoperative Complications | Long-term Outcome

China
Chang Chen
Zunyi Medical College; Ningbo HwaMei Hospital, Zhejiang, China; The First Affiliated... and other collaborators

Recruiting

Deep Learning Model for Pure Solid Nodules Classification

Lung Cancer

China
Southeast University, China

Recruiting

Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China (ECMO)

Extracorporeal Membrane Oxygenation | Long-term Outcome

China
Lin Chen

Completed

Risk of Aspergillus Infection in Patients With Chronic Lung Disease

Fungal Infection Lungs

China
Shanghai East Hospital

Withdrawn

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Long COVID-19

Long COVID-19

China
Southeast University, China

Recruiting

Long-term Outcome of Patients Treated With Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation | Long-term Outcome

China
Shanghai East Hospital
Regend Therapeutics

Completed

Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases

Interstitial Lung Diseases

China
China-Japan Friendship Hospital
Xiangya Hospital of Central South University; Peking Union Medical College... and other collaborators

Unknown

Interstitial Lung Diseases Cohort Study in China (ILD-China)

Interstitial Lung Diseases

China
Children's Hospital of Fudan University

Not yet recruiting

Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes

Interstitial Lung Disease | Surfactant Dysfunction

China
Peking Union Medical College Hospital

Completed

Interstitial Lung Disease Associated

Interstitial Lung Disease

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

Study of the Etiology and Immunological Pathogenesis in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)

Interstitial Lung Diseases

China
Nanfang Hospital, Southern Medical University

Recruiting

Diaphragm Dysfunction After COVID-19 as Determined by Dynamic Chest Radiography (DD-COVID-19)

Long Covid19

China
Peking Union Medical College Hospital

Unknown

The Effects of Glucocorticoids on Glucose Metabolism in Patients With Interstitial Lung Disease

Interstitial Lung Disease

China
Peking Union Medical College Hospital

Recruiting

The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases

Rapid Progressive Interstitial Lung Diseases

China
The First Affiliated Hospital of Dalian Medical...

Recruiting

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Long-Term Effects Secondary to Cancer Therapy

China
Children's Hospital of Fudan University

Active, not recruiting

Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China

Genetic Testing | Interstitial Lung Diseases of Childhood

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

Lung Diseases | Thoracic Neoplasms | Non-small Cell Lung Cancer | Pulmonary Sarcomatoid Carcinoma

China
Guangdong Provincial People's Hospital

Completed

Effects of Exercise Training on Patients With Long COVID-19

Long COVID-19

China
snow
Primary-investigator,Bing Sun

Unknown

Airway Responsiveness in Patients With AECOPD Mechanical Ventilation by Inspiratory and Bronchial Dilation Testchronic Obstructive Pulmonary Disease

Lung Disease,Obstructive

China
Shanghai Chest Hospital

Recruiting

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Limited Stage | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer, Combined Type

China
Li Xuyan

Completed

Prospective Randomized Study of Nasal High Flow in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Lung Diseases, Obstructive

China
Chinese PLA General Hospital

Unknown

The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis (VOCs)

Lung Disease | Lung Neoplasm

China
Peking Union Medical College Hospital

Recruiting

A Real-world Study of Durvalumab for Lung Cancer in China

Non Small Cell Lung Cancer Stage III | Small-Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China
Huashan Hospital; Shanghai Public Health Clinical Center; Anhui Chest Hospital; No.85 Hospital, Changning, Shanghai, China and other collaborators

Not yet recruiting

Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

Nontuberculous Mycobacterial Lung Disease

China
Dizal Pharmaceuticals

Recruiting

DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)

Non-small Cell Lung Cancer

China
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Ruijin Hospital

Recruiting

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Small-cell Lung Cancer

China
Chipscreen Biosciences, Ltd.

Recruiting

A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC

Non Small Cell Lung Cancer

China
Xinqiao Hospital of Chongqing

Recruiting

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

Non Small Cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Recruiting

A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Peking University People's Hospital
Research Unit of Intelligence Diagnosis and treatment of early-stage non-small...

Not yet recruiting

Multiomics Tumor Evolution Model of NSCLC

Non-small Cell Lung Cancer

China
Shouyao Holdings (Beijing) Co. LTD

Recruiting

Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Peking Union Medical College

Recruiting

Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer Patients

Non-small Cell Lung Cancer

China
Peking University Cancer Hospital & Institute

Not yet recruiting

Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC

Non Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer

Small-cell Lung Cancer

China
Shanghai Chest Hospital

Recruiting

Pyrotinib Plus Thalidomide in Advanced NSCLC Patients Harboring HER2 Exon 20 Insertions

Non-small-cell Lung Cancer

China
Peng Zhang

Recruiting

Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung Cancer

Small-cell Lung Cancer

China
Shanghai Chest Hospital

Completed

Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients

Non Small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Simultaneous Integrated Boost vs. Routine IMRT in Limited-stage Small-cell Lung Cancer

Small-cell Lung Cancer

China
Shandong Cancer Hospital and Institute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients

Non Small Cell Lung Cancer

China
Shanghai Pulmonary Hospital, Shanghai, China

Unknown

NGS Combined With RNAseq on Tumor Immune Escape in NSCLC

Non-small Cell Lung Cancer

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

Sintilimab Combined With Metformin in First-Line Chemotherapy Refractory Advanced NSCLC Patients (SMART)

Non Small Cell Lung Cancer

China
Xinqiao Hospital of Chongqing

Terminated

Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC (CERTAIN)

Non Small Cell Lung Cancer

China
Beijing Chest Hospital

Unknown

Endostar Durative Transfusion Combining With Gemcitabine-Cisplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Qilu Pharmaceutical Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
Guangdong Association of Clinical Trials
Changhai Hospital; First People's Hospital of Hangzhou; Fudan University; Henan... and other collaborators

Completed

Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer (ISCAN)

Non-small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Non-small Cell Lung Cancer

China

Clinical Trials on Lung, Hyperlucent in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations